{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:06:35Z","timestamp":1793952395301,"version":"4.8.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.ygyno.2006.03.051","type":"journal-article","created":{"date-parts":[[2006,5,23]],"date-time":"2006-05-23T20:49:47Z","timestamp":1148417387000},"page":"559-564","source":"Crossref","is-referenced-by-count":556,"title":["What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?"],"prefix":"10.1016","volume":"103","author":[{"given":"D.S.","family":"Chi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.L.","family":"Eisenhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.R.","family":"Abu-Rustum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.R.","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2006.03.051_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","article-title":"Cancer statistics, 2005","volume":"55","author":"Jemal","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2006.03.051_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0090-8258(86)90092-2","article-title":"Staging Announcement: FIGO Cancer Committee","volume":"25","year":"1986","journal-title":"Gynecol Oncol"},{"issue":"17","key":"10.1016\/j.ygyno.2006.03.051_bib3","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a gynecologic oncology group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ygyno.2006.03.051_bib4","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ygyno.2006.03.051_bib5","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0002-9378(94)70090-7","article-title":"The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma","volume":"170","author":"Hoskins","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2006.03.051_bib6","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1200\/JCO.1991.9.7.1138","article-title":"Long follow-up and prognostic factor analysis in advanced ovarian carcinoma: the gynecologic oncology group experience","volume":"9","author":"Omura","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2006.03.051_bib7","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1006\/gyno.1994.1346","article-title":"Epithelial ovarian carcinoma: principles of primary surgery","volume":"55","author":"Hoskins","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2006.03.051_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/gyno.1995.1027","article-title":"The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer","volume":"56","author":"Makar","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2006.03.051_bib9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1006\/gyno.1997.4839","article-title":"Does debulking surgery improve survival in biologically aggressive ovarian carcinoma?","volume":"67","author":"Le","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2006.03.051_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/gyno.1998.4955","article-title":"Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study","volume":"69","author":"Eisenkop","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2006.03.051_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/gyno.2001.6344","article-title":"Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator","volume":"83","author":"Bristow","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2006.03.051_bib12","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0090-8258(03)00278-6","article-title":"Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study","volume":"90","author":"Eisenkop","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2006.03.051_bib13","series-title":"International histologic classification of tumors","first-page":"17","article-title":"Histologic typing of ovarian tumors","author":"Serov","year":"1973"},{"issue":"3","key":"10.1016\/j.ygyno.2006.03.051_bib14","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ygyno.2004.01.029","article-title":"Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach","volume":"94","author":"Chi","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2006.03.051_bib15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2307\/2281868","article-title":"Nonparametric estimator from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ygyno.2006.03.051_bib16","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemo Rep."},{"key":"10.1016\/j.ygyno.2006.03.051_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat B"},{"key":"10.1016\/j.ygyno.2006.03.051_bib18","first-page":"101","article-title":"Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma","volume":"42","author":"Griffiths","year":"1975","journal-title":"Natl Cancer Inst Monogr"},{"key":"10.1016\/j.ygyno.2006.03.051_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0090-8258(92)90100-W","article-title":"The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a gynecologic oncology group study","volume":"47","author":"Hoskins","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2006.03.051_bib20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1006\/gyno.2001.6313","article-title":"Procedures required to accomplish complete cytoreduction of ovarian cancer: is there a correlation with \u201cbiological aggressiveness\u201d and survival?","volume":"82","author":"Eisenkop","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2006.03.051_bib21","first-page":"454","article-title":"Gene expression profiling of advanced ovarian cancers to predict the outcome of primary surgical cytoreduction (abstract)","volume":"23","author":"Levine","year":"2004","journal-title":"ASCO Proc"},{"key":"10.1016\/j.ygyno.2006.03.051_bib22","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/1097-0142(19860501)57:9<1725::AID-CNCR2820570903>3.0.CO;2-J","article-title":"A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma","volume":"57","author":"Omura","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2006.03.051_bib23","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/jnci\/dji102","article-title":"Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial","volume":"97","author":"Benedetti Panici","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2006.03.051_bib24","doi-asserted-by":"crossref","first-page":"8802","DOI":"10.1200\/JCO.2005.02.1287","article-title":"Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 trial","volume":"23","author":"Crawford","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2006.03.051_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/gyno.2001.6354","article-title":"Ablation of metastatic ovarian carcinoma with the argon beam coagulator: pathologic analysis of tumor destruction","volume":"83","author":"Bristow","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"24","key":"10.1016\/j.ygyno.2006.03.051_bib26","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1056\/NEJMoa041125","article-title":"Secondary surgical cytoreduction for a advanced carcinoma","volume":"351","author":"Rose","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2006.03.051_bib27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2006.03.051_bib28","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1200\/JCO.20.3.694","article-title":"Intraperitoneal chemotherapy for ovarian carcinoma: results of long-term follow-up","volume":"20","author":"Barakat","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2006.03.051_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0029-7844(98)00334-2","article-title":"Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings","volume":"93","author":"Rubin","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2006.03.051_bib30","unstructured":"McCreath WA, Abu-Rustum NR, Venkatraman ES, Caceres A, Bier R, Huh J, et al. Identification of prognostic factors after positive second look surgery in epithelial ovarian carcinoma. Gynecol Oncol in press."},{"key":"10.1016\/j.ygyno.2006.03.051_bib31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/gyno.1994.1253","article-title":"Reproducibility of tumor measurements in ovarian cancer: a study of interobserver variability","volume":"55","author":"Prefontaine","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2006.03.051_bib32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/gyno.1994.1257","article-title":"The influence of tumor grade, distribution, and extent of carcinomatosis in minimal residual stage III epithelial ovarian cancer after optimal primary cytoreductive surgery","volume":"55","author":"Farias-Eisner","year":"1994","journal-title":"Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825806003209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825806003209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T01:44:24Z","timestamp":1736387064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825806003209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0090825806003209"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2006.03.051","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}